Intapp Highlights AIDriven Demand Growth as Celeste Platform Addresses Compliance Risks Vodafone Idea JP Power Suzlon Energy Davangere Sugar Adani Power Lead NSE Volume on May 26 2026 Sothebys Thwarts Attempt to Sell Counterfeit Ancient Artifacts Fraud Case Highlights Due Diligence in Art Market UK Government Commits 120 Million to Support Ceramics Industry Says Trade Body UK Startup BioOrbit Launches DrugMaking Technology to Space for Cancer Treatment Leonardo Secures 320 Million Deal to Equip Kuwait Patrol Vessels Expanding Italian Defense Presence in Gulf Thor Industries THO Q1 2026 Earnings Massive Earnings Beat Surprises the Market GDRX Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction Tenax Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Amid Continued Clinical Development Griffon Corporation GFF Q1 2026 Earnings EPS Beats Estimates Stock Gains Ground EXK Q1 2026 Earnings EPS Smashes Estimates by Nearly 60 Stock Edges Lower Solarmax Technology Inc Q1 2026 Earnings Minimal Loss Amid Sparse Disclosure San Juan Basin Royalty Trust SJT Edges Higher as Energy Sector Dynamics Provide NearTerm Support Renatus Tactical Acquisition Corp I RTAC Minimal Movement as Stock Hovers Near Trust Value abrdn National Municipal Income Fund VFL Creeps Higher as Yields Stabilize Skyline Builders Group Holding Limited SKBL Struggles Near Support as Selling Pressure Intensifies Trevi Therapeutics TRVI Holds Near Resistance After Modest Gain Signos Raises 20M in Funding Partners with Dexcom to Expand AIPowered Weight Loss Platform MLKN Q1 2026 Earnings EPS Falls Short of Consensus Modestly UHaul Holding Company UHAL Edges Higher Key Resistance in Focus ZIP Q1 2026 Earnings Significant EPS Beat Amid Challenging Job Market TRI Q1 2026 Earnings EPS Beats Estimates by 178 Stock Declines Despite Profit Surprise SREA Q1 2026 Earnings Slight EPS Miss Reflects Modest Operational Headwinds Innoviva INVA Q1 2026 Earnings EPS Misses Estimates by Over 112 Stock Declines AWR Q1 2026 Earnings EPS Misses Estimates by 228 Stock Gains 08 MESO Q1 2026 Earnings EPS Misses Estimates Amid No Revenue Stock Edges Higher Cytokinetics CYTK Q1 2026 Earnings Smaller Loss Than Expected as Pipeline Progress Continues